ABSTRACT
A process developed by a national provider of home infusion therapy to prepare branch pharmacy centers for site surveys by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) is described. Each of the 20 branches to be surveyed by JCAHO was visited three times by a corporate quality assurance team, which consisted of a pharmacy quality assurance manager and a nursing quality assurance manager. During the initial visit, the team performed a baseline quality assurance audit based on pre-established audit criteria. During the second visit, the team conducted a mock survey that replicated the official JCAHO survey. The final visit was scheduled to coincide with the JCAHO survey; its purpose was to provide support to the branch. Results from each of the visits were documented and reviewed with branch and corporate management. As of January 1990, 19 branches and the corporate service had been surveyed. Sixteen branches received a three-year JCAHO accreditation; the JCAHO accreditation status of the remaining three branches is pending. The JCAHO surveyor made only minor recommendations during the oral summary of the survey results. A program for preparing the staff at branch facilities of a major home infusion therapy provider for JCAHO surveys was successful.
Subject(s)
Accreditation , Home Care Services/standards , Infusions, Intravenous , Joint Commission on Accreditation of Healthcare Organizations , Pharmaceutical Services/standards , Infusions, Intravenous/standards , Massachusetts , Quality Assurance, Health CareABSTRACT
Pneumocystis carinii pneumonia (PCP is the most frequent opportunistic infection in patients with AIDS and is the most common cause of death in these patients. Conventional parenteral trimethoprim/sulfamethoxazole or parenteral pentamidine treatment is often not completed because of frequent incidence of adverse reactions. Aerosolized pentamidine appears to be better tolerated and is considered an alternative treatment for PCP in both hospital and community settings. This report describes our experience with 34 patients with AIDS who received aerosolized pentamidine at home. All patients were over 18 years old and had received either parenteral or aerosolized pentamidine within a medically supervised setting before home treatment was initiated. The Respigard II nebulizer system powered by an oxygen source was used as the delivery system. All patients took two puffs of metaproterenol sulfate 10 minutes prior to two 15-minute sessions of pentamidine inhalation. No relapse or adverse reactions were observed in patients. Large randomized clinical trials currently are underway to compare the value of aerosolized pentamidine with other forms of treatment for PCP.
Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Pentamidine/administration & dosage , Adult , Aerosols , Home Care Services , Humans , Nebulizers and Vaporizers , Patient Compliance , Pentamidine/therapeutic useABSTRACT
A comprehensive program to monitor and regulate the activities of medical service representatives (MSRs) in a large teaching hospital is described. The MSR program consists of written policies and procedures for regulating the activities of MSRs within the hospital, an orientation program for MSRs, and quarterly MSR committee meetings. In addition, MSRs are involved in planning and implementing an annual drug fair for all hospital personnel and biannual continuing-education sessions for physicians. Compliance with policies and procedures is monitored using a MSR visitation roster in the pharmacy department. This organized program has resulted in an optimum exchange of information between the hospital and the pharmaceutical industry.
